Clinical trial
Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous…
NCT00002869 · Medical Research Council, Other · Unknown status
Key facts
| NCT number | NCT00002869 |
|---|---|
| Title | Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia |
| Official title | PROSPECTIVE RANDOMISED STUDY TO COMPARE LOW-DOSE INTERFERON-ALPHA-n1 (WELLFERON) +/- HYDROXYUREA VS HIGH-DOSE INTERFERON-ALPHA-n1 (WELLFERON) +/- HYDROXYUREA IN PATIENTS WITH NEWLY DIAGONISED CHRONIC PHASE CHRONIC MYELOID LEUKAEMIA |
| Lead sponsor | Medical Research Council, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Drug |
| Interventions | recombinant interferon alfa, cytarabine, hydroxyurea |
| Enrollment | 800 |
| Start date | Apr 1, 1995 |
| First posted | Feb 16, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: